DTP-poliovirus vaccine - Daiichi Sankyo/Kitasato Institute/sanofi pasteur

Drug Profile

DTP-poliovirus vaccine - Daiichi Sankyo/Kitasato Institute/sanofi pasteur

Alternative Names: 4-valent combination DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; DD-687; DTP-IPV - Kitasato Daiichi Sankyo; DTP-IPV vaccine; DTP-poliovirus vaccine (Squarekids); DTP-poliovirus vaccine - Daiichi Sankyo Kitasato Institute/Sanofi; DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; IPV-DTP - Daiichi Sankyo; Petussis, diptheria, tetanus, inactivated-poliovirus Salk vaccine - Kitasato Daiichi Sankyo; Quadrivalent DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; Squarekids

Latest Information Update: 30 Aug 2016

Price : $50

At a glance

  • Originator Kitasato Institute; sanofi pasteur - Daiichi Sankyo Company (JV)
  • Developer Daiichi Sankyo Company - Kitasato Institute (JV); sanofi pasteur KK
  • Class Bacterial vaccines; Vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 04 Jul 2014 Registered for Tetanus (prevention) in Japan (SC)
  • 04 Jul 2014 Registered for Poliomyelitis (prevention) in Japan (SC)
  • 04 Jul 2014 Registered for Pertussis (prevention) in Japan (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top